Now showing items 1-1 of 1

    • Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. 

      Luedeke, M; Rinckleb, AE; FitzGerald, LM; Geybels, MS; Schleutker, J; Eeles, RA; Teixeira, MR; Cannon-Albright, L; Ostrander, EA; Weikert, S; Herkommer, K; Wahlfors, T; Visakorpi, T; Leinonen, KA; Tammela, TLJ; Cooper, CS; Kote-Jarai, Z; Edwards, S; Goh, CL; McCarthy, F; Parker, C; Flohr, P; Paulo, P; Jerónimo, C; Henrique, R; Krause, H; Wach, S; Lieb, V; Rau, TT; Vogel, W; Kuefer, R; Hofer, MD; Perner, S; Rubin, MA; Agarwal, AM; Easton, DF; Al Olama, AA; Benlloch, S; PRACTICAL consortium; Hoegel, J; Stanford, JL; Maier, C (2016-12-15)
      Molecular and epidemiological differences have been described between TMPRSS2:ERG fusion-positive and fusion-negative prostate cancer (PrCa). Assuming two molecularly distinct subtypes, we have examined 27 common PrCa risk ...